JPMorgan Chase & Co’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.9M | Buy |
1,125,570
+162,939
| +17% | +$7.08M | ﹤0.01% | 1222 |
|
|
2025
Q1 | $36M | Buy |
962,631
+925,376
| +2,484% | +$34.6M | ﹤0.01% | 1346 |
|
|
2024
Q4 | $1.69M | Buy |
37,255
+7,700
| +26% | +$349K | ﹤0.01% | 3503 |
|
|
2024
Q3 | $1.74M | Buy |
29,555
+1,212
| +4% | +$71.2K | ﹤0.01% | 3346 |
|
|
2024
Q2 | $1.12M | Buy |
28,343
+4,010
| +16% | +$158K | ﹤0.01% | 3446 |
|
|
2024
Q1 | $1.62M | Buy |
24,333
+1,269
| +6% | +$84.3K | ﹤0.01% | 3286 |
|
|
2023
Q4 | $644K | Buy |
23,064
+9,830
| +74% | +$275K | ﹤0.01% | 3777 |
|
|
2023
Q3 | $282K | Buy |
+13,234
| New | +$282K | ﹤0.01% | 4030 |
|